Dr Raffaele Califano, Consultant Medical Oncologist

Dr Raffaele Califano

Consultant Medical Oncologist

Book online
|

Dr Raffaele Califano MD, Specialist Diploma in Medical Oncology

Consultant Medical Oncologist

MD, Specialist Diploma in Medical Oncology

Dr Raffaele Califano

Consultant Medical Oncologist MD, Specialist Diploma in Medical Oncology

Book online
|
MD, Specialist Diploma in Medical Oncology
HCA-Healthcare-UK

Areas of expertise

  • Thoracic malignancies
  • Non-small cell lung cancer
  • Small cell lung cancer
  • Thymoma & thymic carcinoma
  • Mesothelioma
HCA-Healthcare-UK

Address

  • The Christie Private Care

    Wilmslow Road, Manchester, M20 4BX

About Dr Raffaele Califano

GMC number: 6153704

Year qualified: 2003

Place of primary qualification: Universita degli Studi di Perugia

Professor Raffaele Califano is a Consultant Medical Oncologist at The Christie and an Honorary Professor at The University of Manchester, Manchester, UK. He graduated in Medicine and Surgery, summa cum laude, from the University of Perugia, Italy, in 2003 and completed his specialist training in Medical Oncology, summa cum laude, in 2007.

Professor Califano is an esteemed investigator for clinical trials in lung cancer and mesothelioma. He has developed a particular interest in molecularly driven clinical trials and immunotherapy, contributing significantly to advancements in these areas. His expertise includes the treatment of non-small cell lung cancer, small cell lung cancer, and mesothelioma.

In addition to his clinical work, Professor Califano is a prolific author, with several papers published in indexed peer-reviewed international journals. He is also a sought-after speaker, having been invited to present at numerous national and international oncology meetings.

Since his appointment, Professor Califano has been dedicated to improving patient outcomes through innovative research and clinical excellence. His commitment to the field of oncology is evident in his ongoing efforts to explore new treatment modalities and improve existing therapies.

Areas of expertise

  • Medical oncology
  • Non small cell lung cancer
  • Small cell lung cancer
  • Thymoma
  • Thymic carcinoma
  • Mesothelioma

Professional memberships

British Thoracic Oncology Group
International Association of Study of Lung Cancer
General Medical Council
European Society for Medical Oncology

Articles by Dr Raffaele Califano

First-line immune checkpoint inhibitors for extensive stage small-cell lung cancer: clinical developments and future directions

Phase i trial of the mek inhibitor selumetinib in combination with thoracic radiotherapy in non-small cell lung cancer

Targeted therapy for ret-rearranged non-small cell lung cancer: clinical development and future directions